Dr. Meena S George , MD, PhD
Ophthalmology • Oak Forest, IL
6320 159th St, Suite A
Oak Forest, IL 604522776
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on September 29, 2010; this date does not establish years in practice.
-
Published CMS data list 25,266 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J2777 — Injection, faricimab-svoa, 0.1 mg: 17,580 service units.
- J2782 — Injection, avacincaptad pegol, 0.1 mg: 1,880 service units.
- J2781 — Injection, pegcetacoplan, intravitreal, 1 mg: 1,470 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
See all 21 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 1,001 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Prednisolone Acetate — 185 prescription fills, including refills.
- Ketorolac Tromethamine — 152 prescription fills, including refills.
- Latanoprost — 144 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 20 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 95% of clinicians listed under Ophthalmology in Illinois (2024, 519 clinicians with data). Median for this group: 1,942. Middle half: 813 to 3,689.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 3,221 in 2020 to 25,266 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
6320 159th St
Suite A
Oak Forest, IL 604522776
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: University Retina And Macula Associates P C. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
Columbia University College Of Physicians And Surgeons
2010
What Public CMS Data Show
Ophthalmology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
381 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $1,834,959 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $1,447,283 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
1,446 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$57,355 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $11,711.32 across 43 records.
By nature of payment
- Consulting Fee: $9,564.00 across 3 records.
- Food and Beverage: $1,472.59 across 37 records.
- Travel and Lodging: $674.73 across 3 records.
Reporting-company totals (3 largest of 11)
- Genentech, Inc.: $7,776.23 across 10 records.
- Astellas Pharma US Inc: $2,260.54 across 5 records.
- Genentech, Inc.: $730.00 across 1 record.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
16 years (graduated 2010)
CMS Doctors and Clinicians data list 2010 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2010
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. George has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. George as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Oak Forest and Illinois
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 95% of clinicians listed under Ophthalmology in Illinois (2024, 519 clinicians with data). Median for this group: 1,942. Middle half: 813 to 3,689.
Too few clinicians listed under Ophthalmology in Oak Forest have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A higher Medicare-allowed amount than 95% of clinicians listed under Ophthalmology in Illinois (2024, 519 clinicians with data). Median for this group: $217,562. Middle half: $82,211 to $445,105.
Too few clinicians listed under Ophthalmology in Oak Forest have Medicare Part B data for 2024 to compare.
Paid by Medicare
A higher Medicare payment amount than 95% of clinicians listed under Ophthalmology in Illinois (2024, 519 clinicians with data). Median for this group: $156,041. Middle half: $58,651 to $322,257.
Too few clinicians listed under Ophthalmology in Oak Forest have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
Close to the middle for clinicians listed under Ophthalmology in Illinois (2024, 570 clinicians with data). Median for this group: 891. Middle half: 294 to 1,971.
Too few clinicians listed under Ophthalmology in Oak Forest have Medicare Part D data for 2024 to compare.
Part D drug cost
Close to the middle for clinicians listed under Ophthalmology in Illinois (2024, 570 clinicians with data). Median for this group: $71,776. Middle half: $10,407 to $185,387.
Too few clinicians listed under Ophthalmology in Oak Forest have Medicare Part D data for 2024 to compare.
4 active clinicians are listed under Ophthalmology with a practice address in Oak Forest, IL (898 in Illinois).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 684% from 3,221 in 2020 to 25,266 in 2024.
- 2020: 3,221
- 2021: 3,712
- 2022: 4,173
- 2023: 12,734
- 2024: 25,266
-
Medicare-allowed amount
Medicare-allowed amount increased 143% from $756,089 in 2020 to $1,834,959 in 2024.
- 2020: $756,089
- 2021: $989,152
- 2022: $1,184,309
- 2023: $1,439,995
- 2024: $1,834,959
-
Paid by Medicare
Paid by Medicare increased 144% from $594,004 in 2020 to $1,447,283 in 2024.
- 2020: $594,004
- 2021: $786,345
- 2022: $929,977
- 2023: $1,132,548
- 2024: $1,447,283
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 114% from 467 in 2020 to 1,001 in 2024.
- 2020: 467
- 2021: 548
- 2022: 644
- 2023: 630
- 2024: 1,001
-
30-day fills
30-day fills increased 152% from 573 in 2020 to 1,446 in 2024.
- 2020: 573
- 2021: 645
- 2022: 779
- 2023: 855
- 2024: 1,446
-
Part D drug cost
Part D drug cost increased 74% from $32,931 in 2020 to $57,355 in 2024.
- 2020: $32,931
- 2021: $56,432
- 2022: $47,751
- 2023: $62,473
- 2024: $57,355
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $99.24 in 2021 to $11,711.32 in 2025.
- 2021: $99.24
- 2022: $500.95
- 2023: $609.33
- 2024: $3,356.16
- 2025: $11,711.32
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 43 records totaling $11,711.32.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Genentech, Inc. |
Consulting Fee
Cash or cash equivalent
|
Vabysmo | General | $6,750.00 |
| Astellas Pharma US Inc |
Consulting Fee
Cash or cash equivalent
|
Izervay | General | $2,084.00 |
| Genentech, Inc. |
Consulting Fee
Cash or cash equivalent
|
Vabysmo | General | $730.00 |
| Genentech, Inc. |
Travel and Lodging
In-kind items and services
|
Vabysmo | General | $296.96 |
| Genentech, Inc. |
Travel and Lodging
In-kind items and services
|
Vabysmo | General | $292.67 |
| Harrow Eye, LLC |
Food and Beverage
In-kind items and services
|
IHEEZO | General | $125.00 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Vabysmo | General | $111.82 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
EYLEA HD | General | $105.39 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Izervay | General | $99.32 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Vabysmo | General | $89.98 |
| Genentech, Inc. |
Travel and Lodging
In-kind items and services
|
Vabysmo | General | $85.10 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Vabysmo | General | $74.99 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
EYLEA HD | General | $39.15 |
| Harrow Eye, LLC |
Food and Beverage
In-kind items and services
|
IHEEZO | General | $37.66 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
EYLEA HD | General | $37.35 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
EYLEA HD | General | $36.92 |
| Harrow Eye, LLC |
Food and Beverage
In-kind items and services
|
IHEEZO | General | $35.28 |
| Apellis Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $35.00 |
| Harrow Eye, LLC |
Food and Beverage
In-kind items and services
|
IHEEZO | General | $33.55 |
| Apellis Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
Syfovre | General | $33.33 |
| Apellis Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $33.33 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Izervay | General | $31.90 |
| Apellis Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $31.00 |
| Harrow Eye, LLC |
Food and Beverage
In-kind items and services
|
IHEEZO | General | $30.34 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Vabysmo | General | $29.66 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J2777
Injection, faricimab-svoa, 0.1 mg
|
17,580 | 46 | $50.17 | $34.40 |
|
J2782
Injection, avacincaptad pegol, 0.1 mg
|
1,880 | 16 | $168.00 | $108.45 |
|
J2781
Injection, pegcetacoplan, intravitreal, 1 mg
|
1,470 | 15 | $294.98 | $146.76 |
|
92134
Imaging of retina
|
1,351 | 378 | $129.00 | $40.63 |
|
67028
Injection of drug into eye
|
704 | 139 | $577.73 | $130.76 |
|
92014
Established patient complete exam of visual system
|
565 | 304 | $402.00 | $126.91 |
|
J0177
Injection, aflibercept hd, 1 mg
|
392 | 11 | $547.00 | $331.31 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
358 | 174 | $409.98 | $131.10 |
|
J0178
Injection, aflibercept, 1 mg
|
352 | 41 | $1162.00 | $826.46 |
|
J9035
Injection, bevacizumab, 10 mg
|
123 | 35 | $300.00 | $69.31 |
|
92012
Established patient problem focused exam of visual system
|
121 | 81 | $284.00 | $88.21 |
|
67210
Destruction of growth of retina using a laser
|
83 | 62 | $1646.00 | $509.80 |
|
92004
New patient complete exam of visual system
|
50 | 50 | $474.00 | $148.87 |
|
76512
2d ultrasound scan of eye tissue and structures
|
41 | 25 | $153.00 | $46.33 |
|
92235
Exam of retinal blood vessels using a special camera after injection of a dye
|
41 | 35 | $399.00 | $165.95 |
|
92250
Photography of the retina
|
41 | 36 | $121.20 | $37.59 |
|
65778
Placement of amniotic membrane on eye surface for wound healing
|
31 | 24 | $4425.00 | $1070.17 |
|
67145
Photocoagulation treatment to prevent detachment of retina
|
31 | 26 | $1691.00 | $248.44 |
|
92083
Exam of visual field with extended testing
|
20 | 18 | $199.00 | $63.16 |
|
92133
Imaging of optic nerve
|
19 | 16 | $117.00 | $32.91 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
13 | 13 | $543.00 | $172.82 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Prednisolone Acetate | Prednisolone Acetate | 185 | 6,199 | $5,498.08 | 97 |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 152 | 5,967 | $2,757.54 | 58 |
| Latanoprost | Latanoprost | 144 | 6,977 | $1,314.77 | 42 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 81 | 5,328 | $836.33 | 37 |
| Brimonidine Tartrate | Brimonidine Tartrate | 80 | 2,990 | $401.06 | 24 |
| Moxifloxacin | Moxifloxacin Hcl | 61 | 930 | $1,261.67 | 44 |
| Ofloxacin | Ofloxacin | 39 | 1,106 | $464.69 | 32 |
| Erythromycin | Erythromycin Base | 36 | 473 | $414.94 | 33 |
| Prolensa | Bromfenac Sodium | 34 | 1,196 | $11,643.30 | — |
| Bromfenac Sodium | Bromfenac Sodium | 24 | 672 | $3,443.99 | — |
| Atropine Sulfate | Atropine Sulfate | 24 | 479 | $584.01 | — |
| Difluprednate | Difluprednate | 19 | 403 | $2,222.03 | — |
| Timolol Maleate | Timolol Maleate | 18 | 1,229 | $90.34 | — |
| Dorzolamide Hcl | Dorzolamide Hcl | 17 | 1,042 | $185.29 | — |
| Tobramycin-Dexamethasone | Tobramycin/Dexamethasone | 16 | 293 | $664.25 | 13 |
| Cyclosporine | Cyclosporine | 15 | 570 | $4,293.33 | — |
| Rhopressa | Netarsudil Mesylate | 15 | 726 | $6,889.89 | — |
| Alphagan P | Brimonidine Tartrate | 14 | 358 | $2,690.14 | — |
| Restasis | Cyclosporine | 14 | 495 | $10,140.89 | — |
| Brinzolamide | Brinzolamide | 13 | 828 | $1,558.58 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2021-12-23NUCC Taxonomy Code: 207W00000X
An ophthalmologist has the knowledge and professional skills needed to provide comprehensive eye and vision care. Ophthalmologists are medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, an ophthalmologist prescribes vision services, including glasses and contact lenses.
NUCC Taxonomy Code: 207WX0107X
An ophthalmologist who specializes in the diagnosis and treatment of vitreoretinal diseases.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - OPHTHALMOLOGY
I20161031002528
IL
2961620661
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
University Retina And Macula Associates P C
6320 W 159th St, Oak Forest, IL 604522780
Phone: 7086872222
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Ophthalmology
Doctor of Medicine (M.D.)
Ophthalmology
Doctor of Medicine (M.D.)
Ophthalmology
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Ophthalmology (license number reported to NPPES: IL 036141259)
NPI status registered as active in NPPES database
Registered at 6320 159TH ST, SUITE A, OAK FOREST, IL 604522776 (Tel: 7086872222)
Registered at 6320 W 159TH STREET, SUITE A, OAK FOREST, IL 60452 (Tel: 7086872222)
Recorded as MEENA GEORGE, M.D., PH.D.
Ophthalmology (license number reported to NPPES: IL 036141259)
NPI status registered as active in NPPES database
Registered at 3800 HIGHLAND AVE STE 105, DOWNERS GROVE, IL 605151558 (Tel: 7086872222)
Registered at 3800 HIGHLAND AVE STE 105, DOWNERS GROVE, IL 605151558
Recorded as MEENA GEORGE, M.D., PH.D.
Ophthalmology (license number reported to NPPES: IL 036141259)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Ophthalmology Specialists in Oak Forest
Mailing Address
6320 W 159th Street, Suite A
Oak Forest, IL 60452
Phone: 7086872222